Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 25 entries
View as:

Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients

Phase: N/A Priority: Normal
NCT ID: NCT01872039 Org: User:
Start: 03/31/13 End: 01/31/14 Due: 01/31/15

A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Phase: N/A Priority: Normal
NCT ID: NCT05152628 Org: User:
Start: 01/11/22 End: 03/06/24 Due: 03/06/25

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

Phase: N/A Priority: Normal
NCT ID: NCT02646774 Org: User:
Start: 03/01/14 End: 06/26/15 Due: 06/26/16

A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections

Phase: N/A Priority: Normal
NCT ID: NCT02678598 Org: User:
Start: 03/31/15 End: 08/31/15 Due: 08/31/16

A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule

Phase: N/A Priority: Normal
NCT ID: NCT02268201 Org: User:
Start: 07/23/13 End: 03/31/15 Due: 03/31/16

Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01720212 Org: User:
Start: 05/31/12 End: 08/31/12 Due: 08/31/13

A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02138773 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT02457221 Org: User:
Start: 03/10/15 End: 09/10/18 Due: 09/10/19

A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04995419 Org: User:
Start: 07/22/21 End: 10/31/25 Due: 10/31/26

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01745159 Org: User:
Start: 09/30/12 End: 11/30/13 Due: 11/30/14

A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause

Phase: N/A Priority: Normal
NCT ID: NCT04451226 Org: User:
Start: 07/30/20 End: 06/13/22 Due: 06/13/23

A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Phase: N/A Priority: Normal
NCT ID: NCT05153915 Org: User:
Start: 12/30/21 End: 03/14/24 Due: 03/14/25

A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)

Phase: N/A Priority: Normal
NCT ID: NCT03660059 Org: User:
Start: 09/27/18 End: 11/02/21 Due: 11/02/22

Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT02392312 Org: User:
Start: 01/21/15 End: 03/16/18 Due: 03/16/19

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

Phase: N/A Priority: Normal
NCT ID: NCT01982071 Org: User:
Start: 09/26/13 End: 08/28/15 Due: 08/28/16

A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04086758 Org: User:
Start: 10/18/19 End: 01/22/21 Due: 01/22/22

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

Phase: N/A Priority: Normal
NCT ID: NCT04234204 Org: User:
Start: 03/17/20 End: 04/20/22 Due: 04/20/23

A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT04501640 Org: User:
Start: 09/21/20 End: 10/27/20 Due: 10/27/21

A Study to Evaluate the Pharmacokinetics and Safety of ASP015K in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04143477 Org: User:
Start: 12/05/19 End: 12/21/20 Due: 12/21/21

Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT03644485 Org: User:
Start: 10/21/18 End: 07/15/22 Due: 07/15/23

A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04793204 Org: User:
Start: 03/24/21 End: 05/21/21 Due: 05/21/22

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Phase: N/A Priority: Normal
NCT ID: NCT02646800 Org: User:
Start: 03/21/14 End: 12/21/14 Due: 12/21/15

An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Phase: N/A Priority: Normal
NCT ID: NCT04076059 Org: User:
Start: 09/11/19 End: 12/31/28 Due: 12/31/29

Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT02706678 Org: User:
Start: 12/29/10 End: 08/01/12 Due: 08/01/13

A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT04562090 Org: User:
Start: 01/06/21 End: 03/30/22 Due: 03/30/23